Structure

InChI Key IEXUMDBQLIVNHZ-YOUGDJEHSA-N
Smile CN(C)c1ccc([C@H]2C[C@]3(C)[C@@H](CC[C@]3(O)CCCO)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1
InChI
InChI=1S/C29H39NO3/c1-28-18-25(19-5-8-21(9-6-19)30(2)3)27-23-12-10-22(32)17-20(23)7-11-24(27)26(28)13-15-29(28,33)14-4-16-31/h5-6,8-9,17,24-26,31,33H,4,7,10-16,18H2,1-3H3/t24-,25+,26-,28+,29+/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C29H39NO3
Molecular Weight 449.64
AlogP 5.16
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 5.0
Polar Surface Area 60.77
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 33.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Progesterone receptor antagonist PubMed Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Prostatic Neoplasms 1 D011471 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials

Related Entries

MCS

Scaffolds

Cross References

Resources Reference
CAS NUMBER 96346-61-1
ChEMBL CHEMBL1908373
DrugBank DB12637
EPA CompTox DTXSID90242210
FDA SRS H6H7G23O3N
Guide to Pharmacology 2882
PubChem 5311505
SureChEMBL SCHEMBL8740
ZINC ZINC000003831947